Bim-A2eT-F4aI

General Information


DRACP ID  DRACP03073

Peptide Name   Bim-A2eT-F4aI

Sequence  RPEIWITQELRRIGDEINAYYAR

Sequence Length  23

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Induce apoptosis Mcl-1 inhibitors BH3 peptides and mimetics



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Mcl-1

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03073

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  5/6-Fluorescein amidite

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C128H200N38O37

Absent amino acids  CFHKMSV

Common amino acids  IR

Mass  325582

Pl  6.64

Basic residues  4

Acidic residues  4

Hydrophobic residues  8

Net charge  0

Boman Index  -7237

Hydrophobicity  -86.09

Aliphatic Index  93.48

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  8480

Absorbance 280nm  385.45

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25052212

Title  Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells

Doi 10.1021/cb500340w

Year  2014

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.